Illumina (ILMN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Illumina Revenue Highlights

Latest Revenue (Y)

$4.34B

Latest Revenue (Q)

$1.08B

Main Segment (Y)

Sequencing

Main Geography (Y)

Americas

Illumina Revenue by Period

Illumina Revenue by Year

Date	Revenue	Change
2025-12-28	$4.34B	-0.69%
2024-12-29	$4.37B	-2.93%
2023-12-31	$4.50B	-1.75%
2023-01-01	$4.58B	1.28%
2022-01-02	$4.53B	39.73%
2021-01-03	$3.24B	-8.58%
2019-12-29	$3.54B	6.30%
2018-12-31	$3.33B	21.11%
2017-12-31	$2.75B	14.74%
2016-12-31	$2.40B	8.05%
2015-12-31	$2.22B	19.25%
2014-12-31	$1.86B	30.97%
2013-12-31	$1.42B	23.74%
2012-12-31	$1.15B	8.81%
2011-12-31	$1.06B	16.93%
2010-12-31	$902.74M	35.48%
2009-12-31	$666.32M	16.24%
2008-12-31	$573.23M	56.28%
2007-12-31	$366.80M	98.71%
2006-12-31	$184.59M	151.13%
2005-12-31	$73.50M	45.31%
2004-12-31	$50.58M	80.43%
2003-12-31	$28.04M	179.23%
2002-12-31	$10.04M	303.86%
2001-12-31	$2.49M	89.90%
2000-12-31	$1.31M	176.17%
1999-12-31	$474.03K	-

Illumina generated $4.34B in revenue during NA 2025, up -0.69% compared to the previous quarter, and up 134.05% compared to the same period a year ago.

Illumina Revenue by Quarter

Date	Revenue	Change
2025-09-28	$1.08B	2.36%
2025-06-29	$1.06B	1.73%
2025-03-30	$1.04B	-5.71%
2024-12-31	$1.10B	2.22%
2024-09-29	$1.08B	-2.88%
2024-06-30	$1.11B	3.35%
2024-03-31	$1.08B	-4.10%
2023-12-31	$1.12B	0.27%
2023-10-01	$1.12B	-4.85%
2023-07-02	$1.18B	8.19%
2023-04-02	$1.09B	0.37%
2022-12-31	$1.08B	-2.87%
2022-10-02	$1.11B	-4.04%
2022-07-03	$1.16B	-4.99%
2022-04-03	$1.22B	2.00%
2021-12-31	$1.20B	8.21%
2021-10-03	$1.11B	-1.60%
2021-07-04	$1.13B	3.02%
2021-04-04	$1.09B	14.69%
2020-12-31	$953.00M	20.03%
2020-09-27	$794.00M	25.43%
2020-06-28	$633.00M	-26.31%
2020-03-29	$859.00M	-9.77%
2019-12-31	$952.00M	4.96%
2019-09-29	$907.00M	8.23%
2019-06-30	$838.00M	-0.95%
2019-03-31	$846.00M	-2.42%
2018-12-31	$867.00M	1.64%
2018-09-30	$853.00M	2.77%
2018-07-01	$830.00M	6.14%
2018-04-01	$782.00M	0.51%
2017-12-31	$778.00M	8.96%
2017-10-01	$714.00M	7.85%
2017-07-02	$662.00M	10.70%
2017-04-02	$598.00M	-3.45%
2017-01-01	$619.35M	2.01%
2016-10-02	$607.14M	1.17%
2016-07-03	$600.12M	4.96%
2016-04-03	$571.76M	-3.34%
2016-01-03	$591.55M	7.50%
2015-09-27	$550.27M	2.02%
2015-06-28	$539.38M	0.15%
2015-03-29	$538.57M	5.11%
2014-12-28	$512.38M	6.61%
2014-09-28	$480.63M	7.39%
2014-06-29	$447.57M	6.37%
2014-03-30	$420.78M	8.64%
2013-12-29	$387.33M	8.56%
2013-09-29	$356.80M	3.09%
2013-06-30	$346.09M	4.57%
2013-03-31	$330.96M	7.01%
2012-12-30	$309.26M	8.18%
2012-09-30	$285.87M	1.88%
2012-07-01	$280.61M	2.87%
2012-04-01	$272.77M	9.08%
2012-01-01	$250.07M	6.19%
2011-10-02	$235.50M	-18.07%
2011-07-03	$287.45M	1.75%
2011-04-03	$282.51M	8.12%
2011-01-02	$261.30M	10.11%
2010-10-03	$237.31M	11.94%
2010-07-04	$212.00M	10.34%
2010-04-04	$192.13M	6.41%
2010-01-03	$180.56M	14.02%
2009-09-27	$158.36M	-2.03%
2009-06-28	$161.64M	-2.48%
2009-03-29	$165.76M	3.00%
2008-12-28	$160.93M	7.10%
2008-09-28	$150.26M	7.19%
2008-06-29	$140.18M	15.03%
2008-03-30	$121.86M	-

Illumina generated $1.08B in revenue during Q3 2025, up 2.36% compared to the previous quarter, and up 97.48% compared to the same period a year ago.

Illumina Revenue Breakdown

Illumina Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 23	Jan 23	Jan 22	Jan 21
Microarray	$358.00M	$392.00M	-	-	-
Sequencing	$3.98B	$4.11B	-	-	-
Core Illumina	-	$4.44B	$4.55B	$4.52B	-
GRAIL, Inc.	-	$93.00M	$55.00M	$12.00M	-
Consolidated Variable Interest Entities	-	-	-	-	-
Product	-	-	-	-	$788.00M
Service, Other	-	-	-	-	$220.00M

Illumina's latest annual revenue breakdown by segment (product or service), as of Dec 25: Sequencing (91.76%), and Microarray (8.24%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Mar 24	Dec 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Sep 20	Jun 20
Sequencing	$1.06B	$1.00B	$972.00M	$947.00M	$995.00M	$979.00M	$1.09B	$1.01B	$1.02B	$979.00M	-	-	-	-	-	-	-	-	-	-
Microarray	$94.00M	$83.00M	$87.00M	$94.00M	$85.00M	$97.00M	$105.00M	$93.00M	$105.00M	$114.00M	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	-	-	$876.00M	$831.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Instruments	-	-	-	-	-	$114.00M	$145.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	-	-	-	-	-	$200.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Consumables	-	-	-	-	-	$762.00M	$686.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Core Illumina	-	-	-	-	-	-	$2.20B	$1.16B	$1.08B	$1.07B	$1.11B	$1.16B	$1.22B	-	-	-	-	-	-	-
GRAIL, Inc.	-	-	-	-	-	-	$51.00M	$22.00M	$20.00M	$23.00M	$10.00M	$12.00M	$10.00M	-	-	-	-	-	-	-
Service, Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$122.00M	$118.00M	$106.00M

Illumina's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Sequencing (91.89%), and Microarray (8.11%).

Illumina Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Jan 23	Jan 22
CHINA	$243.00M	$308.00M	$384.00M	$472.00M	$502.00M
Americas	$2.41B	$2.44B	$2.52B	$2.48B	$2.36B
Asia Pacific	$430.00M	$438.00M	$459.00M	$418.00M	$377.00M
EMEA	$1.26B	$1.19B	$1.14B	$1.22B	$1.29B
UNITED STATES	-	$2.29B	$2.36B	$2.29B	$2.19B
Europe	-	-	$1.14B	-	-

Illumina's latest annual revenue breakdown by geography, as of Dec 25: Americas (55.40%), EMEA (29.10%), Asia Pacific (9.90%), and CHINA (5.60%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Sep 20
CHINA	$56.00M	$52.00M	$63.00M	$72.00M	$155.00M	$75.00M	$78.00M	$178.00M	$115.00M	$91.00M	$94.00M	$133.00M	$118.00M	$127.00M	$120.00M	$122.00M	$132.00M	$127.00M	$96.00M	$83.00M
Americas	$638.00M	$612.00M	$586.00M	$570.00M	$1.23B	$609.00M	$603.00M	$1.26B	$640.00M	$616.00M	$594.00M	$597.00M	$639.00M	$648.00M	$625.00M	$583.00M	$589.00M	$562.00M	$496.00M	$436.00M
Asia Pacific	$113.00M	$111.00M	$100.00M	$106.00M	$94.00M	$95.00M	$97.00M	$132.00M	$103.00M	$90.00M	$85.00M	$99.00M	$77.00M	$62.00M	-	-	-	-	-	-
EMEA	$352.00M	$309.00M	$310.00M	$293.00M	$615.00M	$291.00M	$279.00M	$301.00M	$290.00M	$308.00M	$316.00M	$351.00M	$313.00M	$320.00M	$305.00M	$284.00M	$213.00M	-	-	-
Europe	-	-	-	-	-	-	$279.00M	$576.00M	$303.00M	$261.00M	-	-	-	-	-	-	-	-	-	-

Illumina's latest quarterly revenue breakdown by geography, as of Dec 25: Americas (55.05%), EMEA (30.37%), Asia Pacific (9.75%), and CHINA (4.83%).

Illumina Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
THC	Tenet Healthcare	$21.31B	$5.29B
GMAB	Genmab	$16.47B	$4.14B
LH	Labcorp	$13.95B	$3.56B
DGX	Quest Diagnostics	$11.04B	$2.82B
ZBH	Zimmer Biomet	$8.23B	$2.00B
ICLR	ICON Public	$8.12B	$2.09B
ILMN	Illumina	$4.34B	$1.08B
HOLX	Hologic	$4.10B	-
WAT	Waters	$3.17B	$799.89M
WST	West Pharmaceutical Services	$3.07B	$804.70M
MEDP	Medpace	$2.53B	$659.90M

ILMN Revenue FAQ

What is Illumina’s yearly revenue?

Illumina's yearly revenue for 2025 was $4.34B, representing a decrease of -0.69% compared to 2024. The company's yearly revenue for 2024 was $4.37B, representing a decrease of -2.93% compared to 2023. ILMN's yearly revenue for 2023 was $4.5B, representing a decrease of -1.75% compared to 2022.

What is Illumina’s quarterly revenue?

Illumina's quarterly revenue for Q3 2025 was $1.08B, a 2.36% increase from the previous quarter (Q2 2025), and a 0.37% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.06B, a 1.73% increase from the previous quarter (Q1 2025), and a -4.77% decrease year-over-year (Q2 2024). ILMN's quarterly revenue for Q1 2025 was $1.04B, a -5.71% decrease from the previous quarter (Q4 2024), and a -3.25% decrease year-over-year (Q1 2024).

What is Illumina’s revenue growth rate?

Illumina's revenue growth rate for the last 3 years (2023-2025) was -3.60%, and for the last 5 years (2021-2025) was -4.07%.

What are Illumina’s revenue streams?

Illumina's revenue streams in c 25 are Microarray, and Sequencing. Microarray generated $358M in revenue, accounting 8.24% of the company's total revenue, down -8.67% year-over-year. Sequencing generated $3.98B in revenue, accounting 91.76% of the company's total revenue, down -3.09% year-over-year.

What is Illumina’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Illumina was Sequencing. This segment made a revenue of $3.98B, representing 91.76% of the company's total revenue.